266 related articles for article (PubMed ID: 22425626)
1. Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population.
Hrira MY; Kerkeni M; Hamda BK; Chahed H; Ferchichi S; Addad F; Limam HB; Miled A
Cardiovasc Pathol; 2012; 21(6):455-60. PubMed ID: 22425626
[TBL] [Abstract][Full Text] [Related]
2. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
3. Combined use of high-sensitivity C-reactive protein and apolipoprotein B/apolipoprotein A-1 ratio prior to elective coronary angiography and oral glucose tolerance tests.
Wen ZZ; Geng DF; Luo JG; Wang JF
Clin Biochem; 2011 Nov; 44(16):1284-91. PubMed ID: 21939649
[TBL] [Abstract][Full Text] [Related]
4. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
[TBL] [Abstract][Full Text] [Related]
5. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
[TBL] [Abstract][Full Text] [Related]
6. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease.
Rasouli M; Kiasari AM
Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
9. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease.
Rasouli M; Kiasari AM; Mokhberi V
Clin Chem Lab Med; 2006; 44(8):1015-21. PubMed ID: 16879071
[TBL] [Abstract][Full Text] [Related]
10. Hsp70-2 gene polymorphism: susceptibility implication in Tunisian patients with coronary artery disease.
Hrira MY; Chkioua L; Slimani A; Chahed H; Mosbah H; Khaldoun HB; Ferchichi S; Addad F; Miled A
Diagn Pathol; 2012 Jul; 7(1):88. PubMed ID: 22834788
[TBL] [Abstract][Full Text] [Related]
11. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A is independently related to apolipoprotein A-I but not to HDL-cholesterol in patients with angina pectoris.
Korita I; Bulo A; Langlois MR; Verhoye E; Blaton V
Clin Biochem; 2013 Nov; 46(16-17):1660-3. PubMed ID: 23994331
[TBL] [Abstract][Full Text] [Related]
13. Plasma pyridoxal 5'-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease.
Cheng CH; Lin PT; Liaw YP; Ho CC; Tsai TP; Chou MC; Huang YC
Nutrition; 2008 Mar; 24(3):239-44. PubMed ID: 18312786
[TBL] [Abstract][Full Text] [Related]
14. The Apolipoprotein B/Apolipoprotein A 1 ratio in relation to metabolic syndrome and its components in a sample of the Tunisian population.
Belfki H; Ben Ali S; Bougatef S; Ben Ahmed D; Haddad N; Jmal A; Abdennebi M; Ben Romdhane H
Exp Mol Pathol; 2011 Oct; 91(2):622-5. PubMed ID: 21801720
[TBL] [Abstract][Full Text] [Related]
15. Impact of the apolipoprotein B/apolipoprotein A-I ratio on renal outcome in immunoglobulin A nephropathy.
Lundberg S; Gunnarsson I; Jacobson SH
Scand J Urol Nephrol; 2012 Apr; 46(2):148-55. PubMed ID: 22214235
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
17. Beyond low-density lipoprotein cholesterol: defining the role of low-density lipoprotein heterogeneity in coronary artery disease.
Mudd JO; Borlaug BA; Johnston PV; Kral BG; Rouf R; Blumenthal RS; Kwiterovich PO
J Am Coll Cardiol; 2007 Oct; 50(18):1735-41. PubMed ID: 17964036
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I, apolipoprotein B, and apolipoprotein B/apolipoprotein A-I ratio: reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study.
Leiviskä J; Sundvall J; Alfthan G; Jauhiainen M; Salomaa V
Clin Chim Acta; 2011 May; 412(11-12):1146-50. PubMed ID: 21419755
[TBL] [Abstract][Full Text] [Related]
19. Relation of high-sensitivity C-reactive protein level with coronary vasospastic angina pectoris in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cherng WJ; Yang NI; Cheng CW; Li LF
Am J Cardiol; 2005 Dec; 96(11):1484-90. PubMed ID: 16310426
[TBL] [Abstract][Full Text] [Related]
20. Association between plasma lipids, and apolipoproteins and coronary artery disease: a cross-sectional study in a low-risk Korean population.
Kim HK; Chang SA; Choi EK; Kim YJ; Kim HS; Sohn DW; Oh BH; Lee MM; Park YB; Choi YS
Int J Cardiol; 2005 Jun; 101(3):435-40. PubMed ID: 15907412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
